How to Define Proven Acceptable Ranges During Scale-Up

During a recent scale-up of a biopharmaceutical product, symptoms manifested in both manufacturing and quality control processes. The production line, which had successfully completed multiple small-scale batches, began to show…

How to Set Alert and Action Limits for Robust Scale-Up

Establishing Alert and Action Limits for Effective Scale-Up As pharmaceutical manufacturers transition from development to commercial production, ensuring process robustness at scale becomes paramount. When scaling up, slight variations can…

Process Robustness and Yield Loss: Root Cause Framework

Addressing Process Robustness and Yield Loss: A Root Cause Framework Manufacturing processes in the pharmaceutical industry are often plagued by challenges related to process robustness and yield loss. When deviations…